Precision BioSciences
DTIL
DTIL
128 hedge funds and large institutions have $313M invested in Precision BioSciences in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.01% more ownership
Funds ownership: 1.76% → 1.77% (+0.01%)
6% less call options, than puts
Call options by funds: $1.24M | Put options by funds: $1.32M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
128
Holding in Top 10
–
Calls
$1.24M
Puts
$1.32M
Top Buyers
| 1 | +$26.5M | |
| 2 | +$6.51M | |
| 3 | +$4.06M | |
| 4 |
Citigroup
New York
|
+$3.69M |
| 5 |
Rafferty Asset Management
New York
|
+$2.67M |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$6.32M | |
| 3 | -$3.04M | |
| 4 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$2.73M |
| 5 |
CA
CHI Advisors
New York
|
-$1.66M |